cytokines
New biologic response modifiers       (BRMs) that target specific cells or cytokines involved in the inflammatory       response hold great promise for RA therapy because of their improved efficacy and       limited toxicity.
New biologic response modifiers       (BRMs) that target specific cells or  @SUBJECT$   @PREDICAT$  in the  @OBJECT$  hold great promise for RA therapy because of their improved efficacy and       limited toxicity.